Ferenc Tracik
CIK: 0002120172
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NRSN
NeuroSense Therapeutics Ltd.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Tracik Ferenc
Tracik Ferenc (SEC CIK 0002120172) files insider reports with the SEC as Chief Medical Officer of NeuroSense Therapeutics Ltd. (NRSN).
Signal8 holds 1 ownership filing by Tracik Ferenc, a Form 3, filed on Mar 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Tracik Ferenc's filings is in HERZLIYA.
Other insiders filing for NeuroSense Therapeutics Ltd. (NRSN)
- Eisenberg Or, Chief Financial Officer
- Ben-Noon Alon, Chief Executive Officer
- Russek-Blum Niva, Chief Technology Officer
- Binder Hagit, General Manager
- Pellizzari Christine A, Director
- Claiborne Cary J, Director